Goswami, M T <br/><br/>
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.  [electronic resource] 

 -  Oncogene  Apr 2016 
 - 1888-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2015.258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Animals<br/>CD59 Antigens--biosynthesis<br/>Cell Line, Tumor<br/>Cetuximab--pharmacology<br/>Complement Activation<br/>Complement Membrane Attack Complex--immunology<br/>Cytotoxicity, Immunologic<br/>Epithelial-Mesenchymal Transition--immunology<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Vectors--therapeutic use<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Lung Neoplasms--pathology<br/>Male<br/>Mice<br/>Mice, Mutant Strains<br/>Mice, SCID<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Promoter Regions, Genetic<br/>Proteins<br/>RNA Interference<br/>RNA, Messenger--biosynthesis<br/>RNA, Neoplasm--biosynthesis<br/>RNA, Small Interfering--genetics<br/>Smad3 Protein--physiology<br/>Transcriptome<br/>Transforming Growth Factor beta--pharmacology<br/>Tumor Escape--genetics<br/>Vesicular Transport Proteins<br/>Xenograft Model Antitumor Assays